IMRX(IMRX)
IMRX
ANALYST COVERAGE11 analysts
BUY
▲ +129.9%upside to target
PRICE
Prev Close
5.02
Open
4.95
Day Range4.90 – 5.27
4.90
5.27
52W Range1.40 – 10.08
1.40
10.08
44% of range
VOLUME & SIZE
Avg Volume
875.0K
FUNDAMENTALS
P/E Ratio
-4.9x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.29
Market-like
TECHNICAL
RSI (14)
41
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 96 days
Aug 25
IMRX News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Benjamin J. ZeskindCo-Founder, President, Chief Executive Officer & Director
Brett HallChief Scientific Officer
Praveen NairHead of Translational Pharmacology & Vice President
Harold E. BrakewoodChief Business Officer
Michael D. BookmanChief Legal Officer & Secretary
Robert J. CarpenterCo-Founder & Chair Emeritus
Courtney DuganVP and Head of Investor Relations & Corporate Communications
Mallory MoralesSenior VP of Finance, Chief Accounting Officer & Treasurer
Paula GeorgeDirector of Accounting & Operations and Assistant Corporation Controller
Igor MatushanskyChief Medical Officer
Peter KingHead of Discovery & Vice President
Leah R. NeufeldChief People Officer